GSA Welcomes and Contributes to WHO Work on Sepsis Guidance

The Global Sepsis Alliance welcomes the recent release of the World Health Organization webpage on the clinical management of sepsis and the ongoing work on the WHO Guidelines on Sepsis. Said website was released by the WHO Department of Integrated Health Services (IHS) in January 2024.

GSA commends the leadership and the team of the WHO IHS Department for the work on the new WHO Guidelines on Clinical Management of Sepsis, which are planned to be launched by the end of 2024.

The guidelines will respond to the call by the 2017 World Health Assembly Resolution (WHA 70.7) to develop WHO guidance on the prevention and management of sepsis. The new recommendations will support UN Member States in the development and implementation of national programs for the clinical management of sepsis in adults and children. The Guidelines will be intended for healthcare professionals, policymakers, expert advisers, and technical/program staff at organizations involved in the early identification and clinical management of pediatric and adult patients with sepsis.

Sepsis continues to affect at least 48.9 million children, women, and men every year and remains associated with 1 in every 5  deaths worldwide. Most of these deaths are preventable through effective prevention, early identification, and clinical management of this medical emergency, including effective AMR stewardship.

Therefore, the Global Sepsis Alliances and its Regional Sepsis Alliances look forward to closer collaboration with WHO Geneva Headquarters and respective Regional Offices in assisting with the dissemination of the new WHO Guidelines on the clinical management of sepsis and for the advancement of national and global policies and program capacities in prevention, timely detection, and treatment of sepsis.

Marvin Zick
Kuan Brown’s Sepsis Story: The Death of 18-Year-Old Australian Was Avoidable

The most difficult sentence we have ever had to read has to have been The death of Kuan Brown was avoidable”, as it appeared in the Medical Examiner’s report.

Kuan was our healthy and incredibly fit 18-year-old son, who was training passionately to fulfill his dream of playing college football in America. That dream, and our beautiful boy, were taken from us on Tuesday, 23rd August 2022, when he passed away very unexpectedly due to undiagnosed sepsis.

It was all so sudden. Kuan played football on the weekend. On Monday, he started feeling unwell, and by Wednesday he had a temperature, had started vomiting, and had diarrhea. We arrived at the Emergency Department in the early morning of Thursday but after spending seven and a half hours there, we were sent home with a diagnosis that he “just had a virus” and that we should give him Panadol and Nurofen and keep him hydrated. The reality is, that Kuan had bacterial pneumonia and was in the early stages of sepsis.  Five days later,  he was dead.

The defining day was the Thursday when we took him to the hospital. It was a day marred by an unimaginable series of hospital failures and poor judgments by medical professionals. The triage nurse told us Kuan was fighting an infection and was being categorised as “urgent”, but it was more than three and a half hours until he was even seen by a doctor. She examined him briefly and ordered a reactive protein test, a blood test, and a Covid test. We waited another three hours for the results. We were told the blood results simply showed a viral infection with no further treatment required. We left the hospital mid-afternoon, seven and half hours later, with the clear impression that this was not anything serious.

What emerged after Kuan’s death, was the extent of information that we were not told at the time. Information that was disclosed in the clinical governance investigation report months later, that we believe would almost certainly have saved Kuan’s life, had we been aware of it. The report told us that Kuan was triaged ‘Category 2’, which as per the Australasian Triage Scale, is given to people who need to have treatment within 10 minutes and have an imminently life-threatening condition. Had we been told this and understood what it meant; we would not have waited patiently for three and a half hours to be seen by a doctor. We have never received a satisfactory explanation for why this happened, other than there were an overwhelming number of patients present in the emergency department at the time.

The most concerning finding in the report was that when triaged, Kuan had clearly met the criteria for sepsis as per the New South Wales Health Adult Sepsis Pathway, with an onset of fever, cough, and breathlessness, including two ‘Yellow Zone’ criteria of an elevated heart rate of 137 bpm and a raised temperature of 39.2° C. This should have triggered an immediate response for the medical team to follow the sepsis pathway. It did not. The sepsis pathway stipulates that when a patient presents with two ‘Yellow Zone’ criteria including a new onset of signs and symptoms of infection, a blood gas is obtained to measure lactate, due to a lactate result of equal or above 2 (≥2) being a significant indicator with sepsis. A lactate level was not measured, and blood cultures were not collected. This would have saved his life. It was reported that workload pressures in the emergency department and false reassurance by the junior medical officer’s assessment of Kuan, led to him not having a senior medical review.

The report also confirmed that the doctor that eventually saw Kuan was an International Medical Graduate, who was on ‘Status 1 Supervision’. This meant she should have been under the full supervision of a senior doctor for every patient she examined. She saw Kuan alone, and the Senior Medical Officer on duty at the time, did not see Kuan at any stage. This International Medical Graduate decided to discharge Kuan, without understanding the results of the tests that were done on him. This explanation given in the report was that this junior doctor was placed in a position by the hospital where she was required to make decisions outside of her scope of practice, knowledge, and experience, as a result of not receiving the education, training, and supervision required for junior medical officers.

The c-reactive protein test she administered is a nonspecific blood test for a type of protein associated with inflammation in the body. Essentially it assessed the level of infection and inflammation within Kuan’s body. We now know that 8 to 10 mg/liter or lower is the normal range. Kuan’s result came back at 173ml/liter – 20 times the normal level. Yet, he was discharged with Panadol and Nurofen, just 44 mins after this result was confirmed. His discharge diagnosis was gastroenteritis presumed infectious.

What became evident from the investigation that was conducted on the hospital a few months later, was that 11 years after the New South Wales Health Adult Sepsis Pathway was introduced, it had still not been embedded in the routine practices of this hospital’s emergency department. In fact, the identification and management of sepsis was not mandatory in the junior doctor and international medical graduate orientation program for this hospital, and was the responsibility of individual medical staff to book in and attend. More disturbing was learning that this junior doctor did not even attend hospital orientation. This explains the report’s note that, “the level of appreciation and understanding of the signs of sepsis, in the context of a young person who looked well and reported feeling better following analgesia, led to best practice sepsis management not being commenced.”

We can blame the hospital and the medical professionals entirely. We believe we have good reasons to do that. The reality is though, we didn’t know anything about sepsis at the time. Of course, we are now very aware of the blatantly obvious symptoms, and it makes it harder to comprehend how medical professionals in an emergency department failed to act upon Kuan’s symptoms. What we have come to realise is, that relinquishing our responsibility as parents and relying entirely on health professionals was not necessarily the right thing to do. Had we been aware of the symptoms of sepsis at that time, there is no doubt our beautiful Kuan would still be with us. We believe that we all collectively failed Kuan. This is why we want to share Kuan’s story – none of the results were shared with us or explained to us at any point. Had they been, our lives today would have been very different.

Most of us come from cultures in which we go to hospitals expecting answers and to receive the level of care we need. The reality is, that most healthcare systems are failing to meet the needs of those they serve. They don’t have all the answers. We are not suggesting we all need to become knowledgeable in everything that has the potential to harm us. Instead, we believe it’s about creating a culture of mutual accountability. Our role in that is to be curious. Ask questions and continue to ask questions, until you are satisfied with the responses, and you receive the level of care you need. The other side of mutual accountability is medical services and health professionals adopting a duty of candour. An obligation to share every piece of information with patients and families and demonstrate complete transparency and vulnerability.

Kuan had an enormous impact on so many people during his short life. He invested time in other people and lived his life in such a way that he was a blessing to everyone who knew him. One of his school friends captured the essence of Kuan in her tribute when she said, "Kuan cared for the people around him more than most knew. There is something truly special about a person who can share their passion and their love in ways that push others to try and achieve the same". He was loved and is now deeply missed, by so many. We will continue to fight for more protection for others in a similar situation – because that is what he would have wanted. This is Kuan’s story. The power of our collective stories is what will get us to the next stage!


The article above was written by Duncan and Jolene Brown, Kuan’s parents, and is shared with their explicit consent. The views in the article do not necessarily represent those of the Global Sepsis Alliance. They are not intended or implied to be a substitute for professional medical advice. The whole team here at the Global Sepsis Alliance and World Sepsis Day wishes to thank them for sharing their son’s story and for fighting to raise awareness for sepsis.


Katja Couball
Register for the 7th Annual Meeting of the European Sepsis Alliance, 18 March 2024

Evangelos Giamarellos-Bourboulis, chair of the European Sepsis Alliance, is honored and excited to invite you to join the 7th Annual Meeting of the ESA in Brussels on March 18, 2024.

The whole ESA Steering Committee is delighted to welcome in person and online our friends and stakeholders, to exchange learnings and identify challenges and solutions for the fight against sepsis in Europe. We look forward to hearing the perspectives of prominent leaders on the advances in research, policy, and advocacy.
— Evangelos Giamarellos-Bourboulis, Chair of the ESA

The event “Is Europe Ready to Lead the Global Agenda on Sepsis?” will take place on Monday, March 18, 2024, in Brussels, with registrations now open for both in-person attendance and the free live stream.

2024 is a year of change in many aspects: sepsis is finally being understood by global leaders as a health emergency that must be prioritized and deserves urgent action, if we want to effectively tackle other global priorities such as AMR, pandemic preparedness, patient safety, and health equity.

The European elections on the horizon provide a unique opportunity to include and prioritize sepsis in a renewed European health policy agenda.

Join policymakers, experts, and patients for an engaging discussion that will explore progress, challenges, and successful ways forward in the fight against sepsis in Europe.

Katja Couball
GSA Vice President on Updated NICE Guidelines for Sepsis

On January 31, the UK National Institute for Health and Care Excellence (NICE) released updates to the Sepsis Guidelines (NG51).

The guidance is attended for people with suspected sepsis, their families and carers, as well as healthcare professionals working in primary, secondary, and tertiary care.  The latest edition of the document includes updates to the risk stratification of adults, appropriate timing for antibiotic administration for different risk categories, and the reassertion of the importance of clinical judgment. 

Ron Daniels, the Vice President of the Global Sepsis Alliance and the Founder and CEO of the UK Sepsis Trust (UKST):

We particularly support that the update continues to recommend the identification of high-risk factors, whilst reinforcing the importance of clinical judgment to prevent the injudicious use of antibiotics. The recommendation for GPs and ambulance services to consider how they give antibiotics to people who are at high risk of sepsis is increasingly relevant as transit times increase and could be potentially transformational in terms of patient outcomes.
— Ron Daniels, GSA Vice President

Based on the new NG51 Sepsis Guidelines, the UK Sepsis Trust has ensured relevant updates to its clinical tools for healthcare practitioners.

Ron Daniels further notes that the revised guidelines present an opportunity to deliver a coordinated and cohesive approach to the recognition and management of sepsis across the National Health Service (NHS).

Katja Couball
Stronger Prospects of WHO and GSA Collaboration

Dr. Mariam Jashi – CEO of the Global Sepsis Alliance and Secretary General of the Medical Women’s International Association – attended the WHO Executive Board meeting as part of the Non-State Actors (NSA) delegation and had the opportunity to meet Dr. Tedros Ghebreyesus, WHO Director-General. 

During the visit on January 22-25, Dr. Jashi delivered 2 statements on sepsis at the WHO Executive Board and met the Heads of Departments and colleagues working on different aspects of sepsis prevention, detection, and management.

GSA’s CEO had a working meeting with Dr. Rudi Eggers, Director of WHO HQ Integrated Health Services Department (IHS), and his colleagues - Prof. Benedetta Allegranzi – Unit Head, Infection Prevention and Control (IPC); Lee A. Wallis – Lead of Emergency Care in Clinical Services and Systems and Emilie Calvello Hynes – Technical Officer of Universal Health Coverage-Life Course Division.

The discussion covered updates on the WHO's work on sepsis tools and guidelines, including the newest release of the WHO website on clinical management of sepsis.

Dr. Jashi briefed colleagues on the latest work of GSA, including the Berlin Declaration, the meeting at UNGA78 in New York, the 2023 WHS Side Event on Sepsis, and the ongoing work on the renewed Global Agenda for Sepsis. 

Dr. Jashi had a parallel working meeting with Dr. Nedret Emiroglu – Director of Country Readiness Strengthening for Health Emergencies at WHO. The discussion covered the need for implementation of the WHA 70.7 Resolution on Sepsis in Emergencies and the ongoing work of the department on the CRR framework. 

Briefly, Dr. Jashi had an opportunity to meet Dr. Anshu Banerjee – Director of Maternal, Newborn, Child, and Adolescent Health & Ageing (MCA) Department and looks forward to closer dialogue and partnership, given the alarming burden of Maternal and Neonatal Sepsis. 

Under the leadership of Dr. Eggers, WHO and GSA agreed to strengthen the bilateral partnership, including regular meetings that will engage colleagues from IHS, Emergency, and MCA Departments of WHO and leadership, and the Regional Sepsis Alliances of the GSA.

Katja Couball
Save the Date: April 23, 2024 – World Sepsis Congress Spotlight: Unmet Need in Sepsis Diagnosis and Therapy

Niranjan ‘Tex’ Kissoon, President of the Global Sepsis Alliance, announces the date and theme of the next World Sepsis Congress Spotlight.

On Tuesday, April 23, 2024, the GSA and the Physician-Patient Alliance for Health & Safety (PPAHS) will host the 2024 WSC Spotlight, titled “Unmet Need in Sepsis Diagnosis and Therapy”.

We are delighted to welcome thousands of colleagues from around the world to another unique opportunity to explore and discuss the latest trends and developments in sepsis practice, research, and innovations.
— Niranjan ‘Tex’ Kissoon, President

Dr. Niranjan ‘Tex’ Kissoon

As always, the 2024 WSC Spotlight will be free of charge and completely virtual, enabling broad participation from all parts of the world. For years, the WSCs have engaged between 8,000 and 20,000 scholars and practitioners from more than 180 countries.

Over one day and 9 highly relevant sessions, over 40 internationally renowned speakers, panelists, and moderators will address the role of AI, predictive modeling in sepsis, the need for early diagnosis and treatment of sepsis in surgical patients, the role of biomarkers, personalized approaches to sepsis management, how hypervolemia increases the mortality risk in sepsis, community programs to prevent and diagnose sepsis, and much more.

Whatever topic and speaker is most relevant to you, the Program Chairs Louise Thwaites, Board Member of the GSA and APSA, and Michael Wong, Founder and Executive Director of PPAHS, are excited to welcome you on April 23.

Dr. Louise Thwaites

Michael Wong


Just as with our previous World Sepsis Congresses in 2016, 2018, 2021, and 2023, and WSC Spotlights in 2017, 2020, and 2022, this free online congress brings together highly ranked representatives of international and national healthcare authorities, non-governmental organizations, policymakers, patients, patient advocacy groups, clinical scientists, researchers, and pioneers in healthcare improvement.


We will share more details on the program, speakers, and exact times later this month – stay tuned.

Marvin Zick
Dr. Mariam Jashi Addresses WHO Executive Board to Prioritize Sepsis

Dr. Mariam Jashi, CEO of the Global Sepsis Alliance, addressed the 154th Session of the WHO Executive Board to prioritize sepsis in the Universal Health Coverage (UHC) Agenda as well as the new draft global action plan for infection prevention and control (IPC).

For the advancement of the UHC Agenda, Dr. Jashi called the World Health Organization and Member States to urgently prioritize enforcement of the 2017 World Health Assembly Resolution on Sepsis (WHA70.7).

GSA’s CEO reiterated that “We cannot achieve the health-related Sustainable Development Goals and Universal Health Coverage targets without positioning sepsis in the mainstream of the global health architecture. Every year, this medical emergency affects 48 million people, is associated with 1 in every 5 deaths, and yet receives disproportionally low attention.”

In her second statement, Dr. Jashi commended the draft global action plan for IPC for its comprehensive approach but expressed concern that the document does not address evidence-based policies and programs for sepsis, as the final common pathway to death for many infectious diseases.

She reminded the members of the WHO Executive Board and the EB154 Delegates that every year, sepsis claims the lives of 11 million children, women, and men and that this immense human suffering is mostly preventable through IPC measures.

Finally, Dr. Jashi noted that less than 10% of the UN Member States have enforced the historic 70.7 Resolution of the World Health Assembly and recommended that the global action plan for IPC integrates recommendations and indicators for monitoring the implementation of the 2017 Sepsis Resolution.

Dr. Jashi participated at the WHO Executive Committee Meeting as the Secretary General of the Medical Women’s International Association (MWIA), a Non-State Actor in official relations with WHO and one of the key partners of the Global Sepsis Alliance. GSA therefore extends gratitude to MWIA for this opportunity and positioning the cause of sepsis on the agenda of the WHO EB154.

Please see the full recordings of the 2 statements delivered by Dr. Jashi at the WHO Executive Board meeting in Geneva on January 24, 2024, above and below.

Katja Couball
Maha Aljuaid, Board Member of the GSA, Honored With the Golden Woman Award in Healthcare

In December, Maha Aljuaid – a long-time Board Member of the Global Sepsis Alliance – was honored with The Golden Woman Award, achieving Platinum Level recognition as the most inspiring woman in healthcare. This international award, presented by GOLDEN TREE, recognizes outstanding female achievement.

The award, based on nomination points, has four levels:

  • Gold: 60 to 70 points

  • Diamond: 71 to 80 points

  • Platinum: 81 to 90 points

  • Titanium: Over 91 points

Maha's nomination, in her case by a colleague, was subjected to a rigorous evaluation process by a panel of judges. This included a thorough analysis of her accomplishments, her impact on the healthcare industry, and the lasting impact of her work.

This award is a recognition of seventeen years of outstanding performance in clinical, academic, and leadership as well as a recognition of Maha's role in the global advocacy of sepsis.  

The Golden Woman Award not only recognizes outstanding women but also aims to inspire future generations of female achievers. Maha’s Platinum Level achievement underscores her commitment to excellence in healthcare and sets a standard for others in the industry.

On behalf of the whole team here at the Global Sepsis Alliance, we congratulate Maha on this amazing achievement and are honored to continue to work with her.

Katja Couball